Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
Variable | Hazard ratio | 95% index | p value | Hazard ratio | 95% index | p value |
Serum PSA (ng/mL) (≥7.8 vs. <7.8) | 1.7 | 1.2–2.3 | 0.001 | 1.6 | 1.2–2.2 | 0.005 |
Gleason score (≥ 8vs. ≤7) | 2.0 | 1.4–2.9 | 0.007 | - | - | - |
Extra prostatic extension (1 vs. 0) | 2.4 | 1.7–3.3 | <0.0001 | - | - | - |
Lymphovascular invasion (1 vs. 0) | 1.6 | 1.1–2.2 | 0.009 | 1.4 | 0.9–2.0 | 0.06 |
Perineural invasion (1 vs. 0) | 2.0 | 1.4–2.8 | <0.0001 | 1.8 | 1.3–2.7 | 0.001 |
Resection margin (1 vs. 0) | 3.0 | 2.2–4.1 | <0.0001 | - | - | - |
Lymph node metastasis (1 vs.0) | 3.5 | 1.1–8.2 | 0.004 | - | - | - |
RARP vs RRP | 0.7 | 0.4–0.9 | 0.04 | 0.6 | 0.4–0.9 | 0.009 |